Cloud Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cloud Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11182
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cloud Pharmaceuticals Inc (Cloud Pharmaceuticals), formerly TeraDiscoveries Inc is a drug development company that designs and develops novel drugs and therapies for cancer, inflammation, CNS disorders, and rare diseases. The company offers molecular designs of ligands through its proprietary quantum molecular design process on cloud-based high performance computing platforms. Its proprietary design process includes artificial intelligence and cloud computing to search virtual molecular space and design novel drugs. The company provides therapies and drugs for various diseases such as cancer, dengue fever, autism, leukemia, inflammation, diabetes, PDC deficiency, Crohn’s diseases and sepsis, among others. Cloud Pharmaceuticals is headquartered in Durham, North Carolina, the US.

Cloud Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Cloud Pharma Raises USD0.4 Million in Venture Financing 10
Cloud Pharma Raises USD0.2 Million in Venture Financing 11
Cloud Pharma Raises USD0.3 Million in Venture Financing 12
Partnerships 13
Cloud Pharma Enters into Partnership with GlaxoSmithKline 13
Cloud Pharma Enters into Co-Development Agreement with Therametrics 14
Cloud Pharma Enters into Agreement with Genomeon 15
Cloud Pharma Enters into Agreement with University of Florida Health 16
Myos Enters into R&D Agreement with Cloud Pharma 17
TeraDiscoveries Enters Into Agreement With Egenix To Discover New Cancer And Autism Drugs 18
Cloud Pharma Enters into Agreement with Egenix 19
Cloud Pharmaceuticals Inc – Key Competitors 20
Cloud Pharmaceuticals Inc – Key Employees 21
Cloud Pharmaceuticals Inc – Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cloud Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cloud Pharma Raises USD0.4 Million in Venture Financing 10
Cloud Pharma Raises USD0.2 Million in Venture Financing 11
Cloud Pharma Raises USD0.3 Million in Venture Financing 12
Cloud Pharma Enters into Partnership with GlaxoSmithKline 13
Cloud Pharma Enters into Co-Development Agreement with Therametrics 14
Cloud Pharma Enters into Agreement with Genomeon 15
Cloud Pharma Enters into Agreement with University of Florida Health 16
Myos Enters into R&D Agreement with Cloud Pharma 17
TeraDiscoveries Enters Into Agreement With Egenix To Discover New Cancer And Autism Drugs 18
Cloud Pharma Enters into Agreement with Egenix 19
Cloud Pharmaceuticals Inc, Key Competitors 20
Cloud Pharmaceuticals Inc, Key Employees 21

List of Figures
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cloud Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Cloud Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • North Energy ASA (NORTH):石油・ガス:M&Aディール及び事業提携情報
    Summary North Energy ASA (North Energy) is an upstream oil and gas company that provides exploration and development services in Norwegian Continental Shelf (NCS). The company’s services include oil and gas exploration and development, license mapping and drilling programs, and conducting geological …
  • Assembly Biosciences Inc (ASMB):企業の財務・戦略的SWOT分析
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium diffic …
  • Inner Mongolia Yili Industrial Group Co Ltd
    Inner Mongolia Yili Industrial Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Inner Mongolia Yili Industrial Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Imdex Ltd (IMD):企業の財務・戦略的SWOT分析
    Imdex Ltd (IMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • PT. Asuransi Jiwasraya (Persero):企業の戦略・SWOT・財務分析
    PT. Asuransi Jiwasraya (Persero) - Strategy, SWOT and Corporate Finance Report Summary PT. Asuransi Jiwasraya (Persero) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • SeaSpine Holdings Corporation (SPNE):企業の財務・戦略的SWOT分析
    SeaSpine Holdings Corporation (SPNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sumitomo Seika Chemicals Co Ltd (4008):企業の財務・戦略的SWOT分析
    Sumitomo Seika Chemicals Co Ltd (4008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Ramco Cements Ltd:企業の戦略・SWOT・財務情報
    Ramco Cements Ltd - Strategy, SWOT and Corporate Finance Report Summary Ramco Cements Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ceres Nanosciences Inc:製品パイプライン分析
    Summary Ceres Nanosciences Inc (Ceres Nanosciences) is a provider of sample preparation products and diagnostic tests. The company offers Nanotrap particles for research and development and Nanotrap lyme antigen test that are protein enrichment toolset that can be integrated seamlessly into any exis …
  • Special Metals Corp:企業の戦略・SWOT・財務分析
    Special Metals Corp - Strategy, SWOT and Corporate Finance Report Summary Special Metals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PDF Solutions Inc (PDFS):企業の財務・戦略的SWOT分析
    Summary PDF Solutions Inc (PDF Solutions) is a technology company that offers yield improvement technologies and services for the IC manufacturing process life cycle. The company offers products such as Exensio Control, Exensio Yield, Exensio Test, Exensio Char, Yield Ramp Simulator and Circuit Surf …
  • Sypris Solutions Inc (SYPR):企業の財務・戦略的SWOT分析
    Sypris Solutions Inc (SYPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Central Alabama Electric Cooperative Inc:企業の戦略的SWOT分析
    Central Alabama Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Otto Energy Ltd (OEL):企業の財務・戦略的SWOT分析
    Summary Otto Energy Ltd (Otto Energy) formerly Ottoman Energy Ltd, is an oil and gas company that offers exploration, production, and development of oil and gas properties. The company's products include oil and gas. It operates its exploration properties located in the Offshore Gulf of Mexico such …
  • Commercial Bank Of Ceylon Plc:企業の戦略・SWOT・財務分析
    Commercial Bank Of Ceylon Plc - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank Of Ceylon Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Infigen Energy Ltd (IFN):電力:M&Aディール及び事業提携情報
    Summary Infigen Energy Ltd (IEL) is a major renewable energy company that develops, builds, owns and operates renewable energy generation assets in Australia. It owns interests in several wind farms and a solar farm across New South Wales, South Australia and Western Australia. IEL sells the produce …
  • Molina Healthcare Inc:企業の戦略・SWOT・財務情報
    Molina Healthcare Inc - Strategy, SWOT and Corporate Finance Report Summary Molina Healthcare Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Visa Inc:企業の戦略・SWOT・財務分析
    Visa Inc - Strategy, SWOT and Corporate Finance Report Summary Visa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • PolyNovo Biomaterials Pty Ltd:企業の製品パイプライン分析2018
    Summary PolyNovo Biomaterials Pty Ltd (PolyNovo), a subsidiary of PolyNovo Ltd is a medical technology company that develops, designs and manufactures controlled bioeroding tissue and orthopedic solutions. The company’s Novosorb polymers are based on polyurethanes, a polymer family used in medical a …
  • ProteinSimple-医療機器分野:企業M&A・提携分析
    Summary ProteinSimple, formerly Cell Biosciences Inc, a subsidiary of Bio Techne Corp, is a medical device company that offers protein analysis solutions. The company offers products such as simple plex systems, simple western systems, micro-flow imaging systems, cIEF and CE-SDS; gel documentation s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆